1 Introduction 2 Dyslipidemia is a well-established risk factor for cardiovascular disease and a principal cause of 3 mortality in individuals with type 2 diabetes (T2D). Circulating blood lipid phenotypes are heritable 4 risk factors for the development of atherosclerosis, and their measurements are used clinically to 5 predict future coronary artery disease (CAD) risk and therapy for primary prevention 1, 2 .
6 Epidemiological studies suggest that elevated serum triglyceride (TG) concentration is a strong 7 independent risk factor for CAD 3, 4, 5 . There is an inverse correlation between serum TG and serum 8 high-density cholesterol (HDL-C) that is associated with an increased risk of cardiovascular 9 dysfunction, despite the level of low density cholesterol (LDL-C) being normal. This combination 10 of lipid alterations is defined as atherogenic dyslipidemia, which is a significant risk factor for the 11 development of CAD 6 . Lowering of LDL-C has been the major focus in CAD prevention following 12 treatment with HMG-CoA reductase inhibitors (statins). However, the mortality rate of CAD 13 remains elevated particularly in patients with T2D and insulin resistance, and reasons for their 14 discordant effects in diabetics remain unknown 7 .
16
Family and twin studies have shown that TG and lipoprotein levels aggregate in families 8 .
17
Relatives of individuals with hyperlipidemia/dyslipidemia will have a 2.5-to 7-fold increase in risk 18 of death due to premature CAD compared to relatives of control individuals 9, 10 . The principal lipid 19 alterations observed in these patients include high TG and low HDL-C. The Cincinnati Lipid
20
Research Clinic Family Study showed that low HDL-C and high TG occur conjointly and are 21 transmitted across generations as a "combined phenotype" or "conjoint trait" 11 . Genome-wide 22 association studies (GWAS) and meta-analyses studies on multiethnic populations including 23
Punjabi Sikhs have uncovered more than 200 genetic loci associated with circulating blood lipid 24 phenotypes [12] [13] [14] [15] . However, despite the high clinical heritability (50-80%) of many of the lipid 25 traits 16 , these and several other studies have only explained up to 10% of heritability in these 26 genes. To identify putative functional with larger effects, in this study, we have performed targeted also been automated into our analysis pipeline to produce a standardized, formatted output (VCF-25 variant call format, described above).
1
Replication studies, Population Characteristics, and SNP Genotyping:
2
We replicated the association of three functional variants in an additional 2,355 individuals of 3 Punjabi Sikh ancestry. These included 1,000 individuals from Sikh families and the remaining 4 1,355 were unrelated; all were part of the AIDHS/SDS as described previously 19, 23-25 . Recruitment 5 and diagnostic details of the Sikh replication cohort are similar as described above for the 6 discovery cohort. Clinical and demographical details of these cohorts are provided in Table 1 .
7
Genotyping for selected SNPs was performed using TaqMan pre-designed or TaqMan made-to-8 order SNP genotyping assays from Applied Biosystems Inc. (ABI, Foster City, USA) as described 9 previously 26 . Genotyping reactions were performed on the QuantStudio 6 genetic analyzer using 10 2 uL of genomic DNA (10 ng/uL), following manufacturers' instructions. For quality control, 8-10%
11 replicative controls and negative controls were used in each 384 well plate to match the 12 concordance. Genotyping call rate was 96% or more in all the SNPs studied.
14
Functional Studies using Zebrafish (ZF) Model:
15
To test the phenotypic effects of this and other novel variants in vivo, we created transgenic ZF
16
(Danio rerio) models of the glucokinase regulatory protein (GCKR) mut , and GCKR wt using the TAB-17 5 strain, a commonly used strain derived from two commonly used fish lines (Tubingen and AB).
18
Heterozygous human carriers of this mutation exhibit HTG and high rates of T2D, thus we 19 examined whether GCKR mut induces features of this phenotype in ZF. To build our transgenic 20 models, we employed the Tol2 system, which mediates highly-efficient transgenesis 27 . We used 21 a promoter construct that drives human GCKR mut expression only in hepatocytes, while 22 simultaneously labeling those cells fluorescently. To achieve hepatocyte-specific expression in D.
23 rerio, we used the D. rerio liver fatty acid binding protein (L-FABP) promoter (courteously provided 24 by Dr. Schlegel, University of Utah) 28 . To label GCKR mut expressing D. rerio hepatocytes, we 25 joined the cDNA for human GCKR mut to the enhanced red fluorescent protein (mCherryFP), 26 separated by a 2A peptide linker 27, 29 . The 2A linker is an auto-cleaving peptide, resulting in the 1 GCKR mut and mCherryFP proteins being expressed in a 1:1 stoichiometric ratio. Expression of 2 mCherryFP by the ZF liver confirms expression of GCKR mut hepatocytes ( Figure 1A-C) , and also 3 facilitates purification of GCKR mut -expressing cells by Fluorescence Activated Cell Sorting for 4 downstream analyses. After building GCKR mut transgenic ZF, we evaluated the in vivo metabolic 5 consequences of these human GCKR mutations by feeding high fat diet to 5 day old larvae of 6 wildtype (WT) and transgenic ZF with and without GCKR mutations. 
13
Diet Experiments: For all feeding studies, 5-day post-fertilization (dpf) homozygous humanized 14 GCKR-mutant or -WT transgenic zebrafish larvae were studied. For comparison to WT, we also 15 studied 5 dpf larvae of Tab-5 fish (the parental line used to construct transgenic constructs). All
16
WT and mutant fish were distributed in 3 liter tanks (20 fish per tank) and fed defined diets for 14 17 days. Animals were housed in the main aquarium of the ZF Animal Resource core facility at the 
11
Of a total of 2,709 individuals studied, target sequencing was performed on 940 subjects and 12 1,769 subjects were used for the replication studies. All these participants were part of the 13 AIDHS/SDS [17] [18] [19] . Of the 940 sequenced samples, 820 passed the stringent QC based on multiple 14 parameters and were used for further analysis. (Table 2S) .
19
Our results revealed accumulation of several unknown rare (<1%) and less common variants 20 (<10%) that were not found in any of the existing variant databases. For instance, our results of 21 GCKR sequencing in Sikhs revealed clustering of 13 rare mutations and many of these were 22 predicted to be damaging/ deleterious based on the in-silico prediction methods (Figure 2 A) .
23
Gene-centric analysis for studying the aggregate effects of clustered variants within each gene, 24 revealed a significant burden in GCKR (p=2.1x10 -5 ) along with LPL (p=1.6x10 -3 ) and MLXIPL 25 (p=1.6x10 -2 ), for increasing the risk for HTG (Table 1s ).
1
The present study is further mainly focused on 3 population-specific rare variants identified in the 2 GCKR gene (Figure 2 B) . The first functional variant (S105N), located on the Sugar Isomerase 3 domain -1 (SIS-1), was functionally disruptive and absent in Caucasians (n=33,356), Africans 4 (n=5,197), Hispanic/ Latinos (5,788), and East Asians (n=4,324) in a large Exome Aggregation 5 Consortium (ExAC) of multiethnic populations (Table 2) . Two additional rare functional variants 6 (R297Q and R553W) were also confined to this Sikh population only, and most carriers had HTG 7 (Figure 2A-B, Table 2 ). Two of these three disruptive missense variants (S105N near the fructose 8 binding site and R553W near the GCK interaction domain) were highly conserved across species 9 ( Figure 2D, Figure 3B1 ), while the mutant allele of R297Q variant was also found in cow and 10 sheep in addition to its predominant presence in South Asians ( Figure 3A1) . mutant residue makes it to where the new residue is not in the correct position to make the 20 same hydrogen bond as the original wild-type residue. The wild-type residue was positively 21 charged, the mutant residue is neutral. The mutant residue is more hydrophobic than the wild-22 type residue.
24
The three functionally tested damaging rare mutations in GCKR were at the fructose binding site 25 and GCK binding site at or near the sugar isomerase (SIS-1-2) domains (Figure 2A) . The 1 disruptive allele at codon 105 is predicted to destabilize the folding of the fructose binding domain 2 that results in the loss of a hydrogen bond between Serine (105) and Glutamine (190) ( Figure   3  2E) Tables 3SB-C) .
12
We investigated single variant association of each rare variant with diabetes and quantitative risk 13 phenotypes (e.g. fasting glucose, body mass index (BMI), total cholesterol, LDL-C, HDL-C and 14 TG) in the discovery and replication cohorts. None of these variants showed any significant 15 association with diabetes, fasting glucose or lipid traits (data not shown) except TG. As shown in 16 Based on the significant association of these variants with HTG, we next evaluated the 4 functional consequences of three South Asian population-specific variants by designing a 5 humanized GCKR ZF model. Expression of mCherryFP by the ZF liver confirms expression of 6 GCKR mut hepatocytes (Fig 1A-C) . The H&E liver images of TAB-5, transgenic GCKR wt , and 7 GCKR mut groups with normal diet and HFD are shown in Figure 5A -C. The fat deposition in 8 liver hepatocytes of TAB-5 larvae was increased 3-4-fold in response to HFD. A similar increase 9 in response to HFD was noticed in transgenic fish with wild type GCKR. However, the mutant 10 transgenic fish exhibited a 3-fold increase in ectopic fat in hepatocytes with a normal diet, with 11 80% hepatocytes having fat deposition, while transgenic mutants on HFD had hepatocytes Figure 3S and Figure 4S , respectively. In response to a HFD, 15 mRNA expression of GCKR increased about two folds in normal TAB-5 compared to a normal 16 diet. On the other hand, there was 7-fold increase in GCKR mut larvae even in the absence of 17 HFD; whereas, the GCKR mut mRNA levels were restored to normal when fed on HFD ( Figure   18  4) .
1 Figure 4 . GCKR Relative Expression Levels. Graph summarizes the relative mRNA 2 expression levels of GCKR normalized by beta actin in zebrafish larvae of wildtype (WT) Tab-5 3 and transgenic mutant fish fed on a normal and high fat diet (HFD). Data are presented as 4 mean and standard error of mean using Tab-5 WT as reference. Significant differences in the 5 relative expression of GCKR mRNA (denoted by an asterisk) were detected between Tab-5 6 (WT) and the transgenic mutant on a normal diet; and between transgenic mutants on a normal 7 diet vs. HFD. 
16
Transgenic mutant GCKR fed with a HFD shows 4+ fat with severe cellular damage and higher 17 fatty infiltration than the normal and transgenic normal fish. Most hepatic cells in mutant 18 transgenic fish with and without a HFD contain vacuoles of fat and show severe disorganization 19 of the hepatic structure and hepatocyte nuclei with possible steatosis.
21 Discussion

22
In this investigation, we have attempted to identify functional variants by resequencing 13 known 23 candidate genes of dyslipidemia using an endogamous population of Punjabi Sikhs known to 24 have a high risk for cardiovascular diseases 18, 19, 25, 39 . Despite considerable success of GWAS,
25
whole-genome and exome sequencing, including studies from our group 17, 40-42 , the genetic 1 mechanisms that predispose people to metabolic and cardiovascular disease risk factors remain 2 poorly understood. The degree of clinical heterogeneity existing in the CAD or cardiometabolic 3 phenotypes imposes serious limitations in our ability to effectively measure genetic risk, 4 environmental exposure, and their interactions. Additionally, most post-GWA studies on 5 candidate gene sequencing have predominantly been focused on European populations which 6 provide limited information on the usefulness of variants in populations of non-European ancestry.
7
Moreover, the post-GWAS exome arrays could capture the majority of low-frequency variants in 8 European populations only when the sample size exceeds >300,000 43 . However, such studies in 9 other disparate populations are sparse. The current investigation in family and population based 10 samples from the AIDHS/SDS is an effort to identify missing heritability associated with GWAS-11 driven loci of dyslipidemia, specifically the HTG by using candidate gene resequencing.
13
As expected, the AIDHS/SDS, being an endogamous and relatively homogenous population, was 14 enriched with rare and less common variants. Enrichment of functional variants in cases with
15
HTG along with our focus on individuals with extreme trait (TG) values, increased our power to 16 discover pathogenic variants and aided the discovery of multiple novel/ rare and common/ known 17 variants in splice regions, 5'UTRs, 3'UTRs, intronic, and missense (loss-of-function) variants.
18
Moreover, this ethnic subgroup of Sikhs from North India were enrolled from one single 19 geographic location with shared environmental and cultural traits, which further has reduced the 20 environmental and cultural heterogeneity.
22
Gene-centric analysis of the identified variants revealed a significant burden of variants for 23 increased HTG risk in GCKR (p=2.1x10 -5 ), LPL (p=1.6x10 -3 ) and MLXIPL (p=1.6x10 -2 ). The
24
GCKR is glucokinase regulatory protein that inhibits glucokinase (GCK) by forming a complex 25 with the enzyme in the liver, which plays a role in glucose homeostasis 44 Figure 2SB) . Due to the absence of 386 13 amino acids in the ZF GCKR gene, our three functional variants fall outside the ZF GCKR protein.
15
Despite this dissimilarity, ZF are a well-suited model for studies involving human energy 16 metabolism because the pathways of lipid storage and transport are conserved across species 49 .
17
Further, dietary studies performed in the ZF model for developing atherosclerosis and hepatic 18 steatosis in response to a high-cholesterol diet, revealed the potential strength of this model for 19 analyzing diet-induced phenotypes 50 . In this study, the ZF larvae exposed to a HFD and normal 20 diet, revealed a 2 to 3 fold increase of fat accumulation in hepatocytes in response to the HFD in 21 both TAB-5 and control transgenic fish (normal human GCKR) with no apoptosis. However, the 22 observed 4-fold increase in liver fat accumulation with at least one apoptotic cell every hundred 23 hepatic cells, even in the absence of HFD in transgenic GCKR mut , suggests the impaired function 24 of GCKR due to mutations, which may prevent GCKR from acting promptly in response to the 25 increased concentration of fructose 6-phosphate. This consequently would lead to the 1 uninterrupted release of GCK in the liver to result in the increased uptake of glucose and 2 eventually leading to de novo lipogenesis 51 . Alternatively, studies suggest that GCKR stabilizes 3 and protects GCK from degradation. Thus, the increased expression with impaired function of 4 GCKR may result in reduced GCK activity or function, which would give rise to impaired glucose 5 tolerance and hepatic fat accumulation 52 . Evidently, from these studies it appears that the GCKR 6 could be a thrifty gene and the functionally disrupted variants in the GCKR in Punjabi Sikhs may 7 enhance ectopic fat storage defects even in the absence of HFD, as revealed in the transgenic 8 ZF. Not only did most hepatic cells contain vacuoles of fat, but the structure of hepatocytes was 9 disorganized due to fatty metamorphosis and severe disorganization of the hepatic structure and 10 hepatocyte nuclei with possible steatosis in the absence of HFD in GCKR mut compared to GCKR wt 11 or WT (TAB-5) Figure 5C . 
10
The uneven distribution of fat in insulin sensitive organs like the liver or pancreas increases the 11 risk for development of insulin resistance, T2D, and non-alcoholic fatty liver disease (NAFLD) 66 ,
12
which are common in Indians. Based on the results of this study, carriers of these evolutionarily 13 conserved variants (specifically S105N and R553W), will have a high risk of ectopic fat deposition 14 and an increased risk for NAFLD in the absence of overt obesity.
16
Overall, successful humanized transgenic GCKR mut -expressing D. rerio has provided a platform 17 for our ongoing studies to define the precise mechanisms of metabolic derangement perhaps by 18 modulating the GCKR-GCK complex leading to HTG and T2D in humans. Limitations of our study 19 include the lack of data on GCK mRNA, GCKR/GCK protein quantification and GCK activity, 20 which may provide more insight on the putative effects of functional mutations on regulation of 21 GCKR, and clarify the effects of exposure of HFD on the humanized ZF. Our results agree with 22 the earlier reports of targeted improvement of GCK activity by liver-specific GCKR inhibition, 23 which may lower the risk of HTG 45 .
25
In summary, our study for the first time reports causal role of rare disruptive variants in GCKR for 26 increasing serum TG levels independent of T2D in Punjabi Sikhs. These results may also partly 1 support the "non-obese-metabolic obese phenotype" of Asian Indians linked to increased risk for 2 developing cardiovascular diseases.
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1 Supplementary Figure 3S . Additional supplemental figures of WT and transgenic Zebrafish 2 livers at 40X magnification.
3 Supplementary Figure 4S . Additional supplemental figures of WT and transgenic Zebrafish 4 livers at 4X magnification.
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